ID: ALA5269730

Max Phase: Preclinical

Molecular Formula: C16H14O7

Molecular Weight: 318.28

Associated Items:

Representations

Canonical SMILES:  COc1cc(OC)c2c(=O)c3c(O)c(OC)ccc3oc2c1O

Standard InChI:  InChI=1S/C16H14O7/c1-20-8-5-4-7-11(13(8)17)15(19)12-9(21-2)6-10(22-3)14(18)16(12)23-7/h4-6,17-18H,1-3H3

Standard InChI Key:  DJDYBFKZTGFFHB-UHFFFAOYSA-N

Associated Targets(non-human)

Alpha-glucosidase 187 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Topical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Properties

Molecular Weight: 318.28Molecular Weight (Monoisotopic): 318.0740AlogP: 2.38#Rotatable Bonds: 3
Polar Surface Area: 98.36Molecular Species: NEUTRALHBA: 7HBD: 2
#RO5 Violations: 0HBA (Lipinski): 7HBD (Lipinski): 2#RO5 Violations (Lipinski): 0
CX Acidic pKa: 8.63CX Basic pKa: CX LogP: 2.53CX LogD: 2.50
Aromatic Rings: 3Heavy Atoms: 23QED Weighted: 0.72Np Likeness Score: 1.36

References

1. Santos CMM, Freitas M, Fernandes E..  (2018)  A comprehensive review on xanthone derivatives as α-glucosidase inhibitors.,  157  [PMID:30282319] [10.1016/j.ejmech.2018.07.073]

Source